Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit Manero, G., Atallah, E., Khaled, S. K., Arellano, M., Patnaik, M. M., Odenike, O., Sayar, H., Tummala, M., Patel, P. A., Ghalie, R. G., Medeiros, B. C. AMER SOC HEMATOLOGY. 2016
View details for Web of Science ID 000394446803016